4//SEC Filing
Hamel Lawrence G 4
Accession 0001437749-18-001229
CIK 0001427925other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 7:29 PM ET
Size
5.3 KB
Accession
0001437749-18-001229
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-01-22+95,000→ 95,000 totalExercise: $2.00From: 2019-01-22Exp: 2028-01-21→ Common Stock (95,000 underlying)
Footnotes (2)
- [F1]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
- [F2]Issued pursuant to the 2011 Equity Incentive Plan.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 7:29 PM ET
- Size
- 5.3 KB